Niche Ophthalmology CRO Target ophthalmology-focused biotech and pharmaceutical clients seeking specialized clinical research management, highlighting Trial Runners’ domain expertise and potential for high-value partnerships in eye disease trials.

SMB-Scale Growth Operate in the small-to-medium enterprise segment with 11-50 employees and annual revenue in the 1M-10M range, presenting opportunities to upsell comprehensive CRO services as clients scale their ophthalmology programs.

Proven Track Record Leverage a history of over 70 ophthalmology studies since 2006 to build credibility with potential clients seeking reliable execution, faster study timelines, and demonstrated regulatory-compliant study management.

Digital Maturity Utilize a modern, albeit modest, tech stack and a refreshed website to highlight capabilities; pursue digital marketing and lead-gen partnerships to increase inbound inquiries from biotech companies seeking ophthalmology trial support.

Revenue Upsell Paths With revenue already in the lower-mid range and a mission to be the top ophthalmology CRO, identify opportunities to expand services (e.g., centralized data management, patient recruitment, site management, regulatory affairs) for existing clients and adjacent ophthalmology indications.